Affiliation:
1. Adnan Menderes University, Medical Faculty, Department of Thoracic Surgery, Aydın-TURKEY
2. Adnan Menderes University, Medical Faculty, Department of Biochemistry, Aydın-TURKEY.
3. Adnan Menderes University, Medical Faculty, Department of Thoracic Surgery, Aydın-TURKEY.
4. n Adnan Menderes University, Medical Faculty, Department of Biochemistry, Aydın-TURKEY.
5. Adnan Menderes University, Medical Faculty, Department of Chest Diseases, Aydın-TURKEY.
Abstract
Objectives: The number of human studies on the association and clinical signicance of alterations in
IL-6, sP-Selectin, TNF-α, BNP-32, or procalcitonin (PCT) in lung cancer is small. We aimed to investigate
the alterations of proinammatory cytokines and acute-phase reactants in blood and pleural uid and determine their clinical
diagnostic or prognostic signicances regarding tumor type, stage, size, standardized uptake value (SUV), and
lymphovascular invasion (LVI). Methods: Levels of IL-6, TNF-α, BNP-32, PCT, and sP-selectin were evaluated in blood samples
st th st th th obtained preoperatively and postoperatively on 1 , 6 hours and 1 , 4 , and seven days. They also were evaluated in pleural
st uid samples obtained postoperatively on 1 hour, and rst and fourth days. These results were analyzed according to the cell
type, size, stage, SUV, and LVI of lung cancer. IL-6 values in plasma and pleural uid had Results: various signicant
relationships and correlations with histological type, diameter, SUV, stage, and LVI of the tumor. TNF-α values in plasma or
pleural uid had signicant relationships with LVI only. PCT values in plasma or pleural uid had signicant relationships with
the tumor's diameter, SUV, and LVI. BNP-32 values in plasma or pleural uid had signicant relationships with histological type
and SUV of the tumor. sP-Selectin values in plasma or pleural uid had signicant relationships with the stage and SUV of the
tumor. We determined various signicant associations and correlations of proinammatory cytokines wi Conclusions: th
histological type, size, stage, LVI, and SUV of lung cancer. Studies on this subject would serve to develop diagnostic and
prognostic methods in lung cancers.